Impact of Impella Support on Clinical Outcomes in Patients with Postcardiotomy Cardiogenic Shock.

ABSTRACT:

Purpose

This study aimed to elucidate the strategy of an effective Impella support for better clinical outcomes in patients with a postcardiotomy cardiogenic shock (PCCS).

Methods

This single-center retrospective observational study enrolled 31 patients with PCCS undergoing an elective open-heart surgery followed by Impella support between November 2018 and February 2022 for further analysis.

Results

The preoperative Euroscore II and left ventricular (LV) ejection fraction were 9.1 ± 10.4 and 35.7% ± 12.6%, respectively. The in-hospital mortality rate was 51.6% (n = 16). In survivors (n = 15), the mean Impella support time was 6.9 ± 3.5 days. Patients were discharged on the postoperative day 24.9 ± 16.4. Regarding LV remodeling, LV end-diastolic diameter was significa

SUBMITTER: Sugimura Y 

PROVIDER: S-EPMC10902663 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature